0001123292-17-001446.txt : 20170928
0001123292-17-001446.hdr.sgml : 20170928
20170928171443
ACCESSION NUMBER: 0001123292-17-001446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170928
DATE AS OF CHANGE: 20170928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danilkovitch Alla
CENTRAL INDEX KEY: 0001636236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 171108313
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
STREET 2: OSIRIS THERAPEUTICS, INC.
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-07-19
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001636236
Danilkovitch Alla
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
Chief Scientific Officer
Incentive Stock Option (right to buy)
6.80
2017-07-19
4
A
0
34534
6.80
A
2018-07-19
2027-07-19
Common Stock
34534
125534
D
Non-qualified Stock Option (right to buy)
6.80
2017-07-19
4
A
0
15466
6.80
A
2018-07-19
2027-07-19
Common Stock
15466
139000
D
25% of the shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Alla Danilkovitch
2017-09-28